Should COVID-19 survivors go in the background for the Pfizer or Moderna vaccine?

A record number of new COVID-19 infections fill hospitals and morgues across the country just days before the U.S. Food and Drug Administration approves the first coronavirus vaccine for emergency use. But there is a perverse glimmer of hope to this deadly spike in infections: Every American who catches and recovers from COVID has a chance to retain some degree of immunity for months, if not years, all without it. using a vaccine that is expensive and difficult to distribute.

These millions of former COVID patients and their persistent antibodies and T cells could contribute to population-level immunity that could signal the end of the current pandemic. In a strange and tragic way, America’s massive failure to slow COVID infections co-pre-vaccineuld would actually help speed up post-vaccine immunization efforts by reducing, potentially by tens of millions, the number of Americans who need vaccines.

welcome to Rabbit hole, where we dig deeper into the bigger story. This is reserved for members of Beast Inside. Join us today.

#COVID19 #survivors #background #Pfizer #Moderna #vaccine

Jessica Kirson on Bill Burr, Robert de Niro, and being the wrong ‘kind’ of comedian

Rudy Giuliani’s COVID Case Shows There Is No Vaccine To Treat The Disease The GOP Has Become